Anchor Investment Management’s Alnylam Pharmaceuticals ALNY Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$65.2K	Hold	200	–	–	0.01%	543
2025 Q1	$54K	Hold	200	–	–	0.01%	555
2024 Q4	$47.1K	Hold	200	–	–	﹤0.01%	582
2024 Q3	$55K	Hold	200	–	–	0.01%	551
2024 Q2	$48.6K	Hold	200	–	–	0.01%	523
2024 Q1	$29.9K	Hold	200	–	–	﹤0.01%	614
2023 Q4	$38.3K	Hold	200	–	–	﹤0.01%	557
2023 Q3	$35.4K	Hold	200	–	–	﹤0.01%	559
2023 Q2	$38K	Hold	200	–	–	﹤0.01%	549
2023 Q1	$40.1K	Hold	200	–	–	0.01%	559
2022 Q4	$47.5K	Hold	200	–	–	0.01%	531
2022 Q3	$40K	Hold	200	–	–	0.01%	542
2022 Q2	$29.2K	Hold	200	–	–	﹤0.01%	597
2022 Q1	$32.7K	Hold	200	–	–	﹤0.01%	601
2021 Q4	$33.9K	Hold	200	–	–	﹤0.01%	616
2021 Q3	$37.8K	Hold	200	–	–	0.01%	558
2021 Q2	$33.9K	Hold	200	–	–	﹤0.01%	580
2021 Q1	$28.2K	Hold	200	–	–	﹤0.01%	584
2020 Q4	$26K	Hold	200	–	–	﹤0.01%	562
2020 Q3	$29.1K	Hold	200	–	–	0.01%	516
2020 Q2	$29.6K	Hold	200	–	–	0.01%	503
2020 Q1	$21.8K	Hold	200	–	–	0.01%	523
2019 Q4	$23K	Hold	200	–	–	﹤0.01%	552
2019 Q3	$16.1K	Hold	200	–	–	﹤0.01%	589
2019 Q2	$14.5K	Hold	200	–	–	﹤0.01%	600
2019 Q1	$18.7K	Hold	200	–	–	﹤0.01%	564
2018 Q4	$14.6K	Hold	200	–	–	﹤0.01%	577
2018 Q3	$17.5K	Hold	200	–	–	﹤0.01%	582
2018 Q2	$19.7K	Hold	200	–	–	﹤0.01%	582
2018 Q1	$23.8K	Hold	200	–	–	0.01%	555
2017 Q4	$25.4K	Buy	+200	New	+$25.4K	0.01%	544